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ABSTRACT 
The relation between ACTN3 R577X polymorphism and muscle mass in 
women has been reported, but its relation to age remains unclear. We investigated the 
relationship between ACTN3 R577X polymorphism and muscle mass in both 
middle-aged and elderly women. Two age groups (middle-aged and older) were divided 
of 162 healthy, non-training Japanese women (mean ± SE, 58.6 ± 0.8 yr). Their 
mid-thigh muscle cross-sectional area (CSA) was assessed using MRI, revealing no 
difference in thigh-muscle CSA among ACTN3 R577X genotypes in the middle-aged 
group (XX, 87.3 ± 2.5 cm2; RR&RX, 86.1 ± 1.7 cm2, P = 0.7). In contrast, the XX 
genotype in the older group had a smaller thigh-muscle CSA adjusted to body weight 
than the RR&RX genotype (XX, 67.8 ± 2.0 cm2; RR&RX, 72.5 ± 1.2 cm2, P < 0.05). 
The present study showed an association between ACTN3 R577X polymorphism and 
smaller thigh-muscle CSA in a group of elderly women, but not in a group of 
middle-aged women. 
 
 
 
INTRODUCTION 
Elderly populations are growing around the world because of increasing life 
expectancy. The United Nations reported that the number of people over 60 years old 
was 600 million in 2000. It is expected to rise to 2 billion by 2050 (United Nations, 
2008). Japan has now entered the “super-aged society” stage, with elderly population 
constituting more than 23% of the population, which no other country in the world has 
ever experienced (Cabinet office Japan, 2008). Japan is increasingly confronting 
problems associated with it aging population. The rapidly increasing number of elderly 
people in need of care is especially important. About 4.8 million elderly people need 
care in Japan, of whom 65.9% are women (Ministry of Health, Labour and Welfare 
Japan, 2007).  
 
 Musculoskeletal disorders are a leading contributors to increased health care 
needs of elderly people. Sarcopenia characterized by a loss of skeletal muscle mass and 
strength concurrent with aging, is positively related to mobility disorders, increased risk 
of falls and fractures, and risk of death (Cruz-Jentoft et al., 2010). The estimated direct 
healthcare cost attributable to sarcopenia in the United States in 2000 was $18.5 billion 
(Janssen et al., 2004). Therefore, developing appropriate prevention and treatment 
 
 
strategies for sarcopenia is becoming an increasingly important public health concern. 
Sarcopenia characteristics include significantly less leg muscle mass than arm muscle 
mass (Janssen et al., 2000), and selective atrophy of type II muscle fibers (Kamel, 2003). 
Both genetic and environmental factors influence muscle mass. A twin report described 
that the lean body mass of postmenopausal women has a moderate genetic component 
with heritability estimates of 52% (Arden and Spector, 1997). However, the relation 
between individual variations of gene and muscle mass ramains unclear. 
  
 The actin-binding protein α-actinin is an important protein related to muscle 
contraction, it is a structural component of the Z-lines in skeletal muscle (Masaki et 
al., 1967). The α-actinin isoform, α-actinin 3 (ACTN3), is observed only in type II 
fibers (North et al., 1996 and 1999). However, one billion people are homozygous 
recessive for ACTN3 (Chr. 11q13.2) R577X polymorphism (rs1815739), which 
causes complete deficiency of ACTN3 (XX genotype). Previous reports have 
described that ACTN3 R577X polymorphism is related to muscle strength (Clarkson 
et al., 2005; Vincent et al., 2007; Walsh et al., 2008), walking ability (Delmonico et 
al., 2008), and athletic status (Yang et al., 2003). These findings also show that 
sex-specific genotype differences for ACTN3 R577X polymorphism, specially 
 
 
observed in women (Clarkson et al., 2005; Walsh et al., 2008; Delmonico et al., 
2008; Yang et al., 2003). Few studies have investigated the relation between ACTN3 
R577X polymorphism and muscle mass in women (Clarkson et al., 2005; Walsh et al., 
2008; Delmonico et al., 2008; Zempo et al., 2010; Delmonico et al., 2007). Walsh et 
al. (2008) demonstrated that the XX genotype has lower fat-free mass than the 
RR&RX genotype in women across the adult age span. Recently, we reported that the 
XX genotype has a smaller thigh-muscle cross-sectional area (CSA) than the 
RR&RX genotype in older women (Zempo et al., 2010). However, another report 
described that a younger cohort showed no link between ACTN3 R577X 
polymorphism and arm muscle CSA (Clarkson et al., 2005). Consequently, the 
influence of ACTN3 R577X polymorphism on muscle mass is observed in older 
women, not in younger women. These findings suggest that the influence of ACTN3 
R577X polymorphism on muscle mass change with ageing. Nevertheless, it remains 
unclear the association between ACTN3 R577X polymorphism and age. Because of 
an accelerated loss of muscle mass occurs during middle-age in women (Maltais et al., 
2009), we aim to investigate the relationship between ACTN3 R577X polymorphism 
and muscle mass in both middle-aged and elderly women. 
 
 
 
 
 
METHODS 
Subjects 
This cross-sectional study examined 162 healthy Japanese women (means ± SE, 
58.6 ± 0.8 years). The subjects were non-smokers who did not have significant 
cardiovascular, metabolic or musculoskeletal disorders. None of the women had taken 
antidepressant, hypolipidemic or hormonal drugs. The study was approved by the 
Ethical Committees of the Institute of Health and Sport Sciences and the Institute of 
Clinical Medicine of the University of Tsukuba. The study conformed to the principles 
outlined in the Declaration of Helsinki. Written informed consent was obtained from all 
subjects before their inclusion in the study. 
 
Genotyping 
The genotype of ACTN3 R577X polymorphism was identified as described 
previously (Zempo et al., 2010). Genomic DNA was prepared from EDTA-whole blood 
samples using a kit (QIAamp DNA Blood mini kit; Qiagen. Tokyo, Japan). Genotyping 
for ACTN3 R577X polymorphism was determined by real-time polymerase chain 
 
 
reaction assays using TaqMan probes (Pre-Designed SNP Genotyping assays; Applied 
Biosystems, Tokyo, Japan) and a sequence detector (ABI Prism 7700; Applied 
Biosystems, Foster City, CA). The oligonucleotide sequences were as follows: 
ACTN3 forward: 5'-ACGATCAGTTCAAGGCAACACT-3' 
ACTN3 reverse: 5'-ACCCTGGATGCCCATGATG-3' 
ACTN3/R probe: 5'-TCGCTCTCGGTCAGC-3' 
ACTN3/X probe: 5'-CGCTCTCAGTCAGC-3' 
 
Thigh-muscle cross-sectional area 
Thigh-muscle CSA was determined by magnetic resonance imaging (MRI). 
Each subject’s right foot was visualised by MRI (0.25 Tesla, AIRIS Mate; Hitachi 
Medical, Tokyo, Japan). All the cross-sectional MRI scans were obtained using a 
conventional T1-weighted spin-echo sequence (28 ms echo time, 360 ms repetition 
time), with a 10 mm slice thickness, a 20 mm intersection interval, a 240 mm field of 
view, 256 × 180 matrix, 90° flip angle and 4 signals on an average. Cross-sectional 
images of the thigh were obtained at 50 % of femur length, corresponding to the site of 
highest correlation thigh-muscle volume in middle-aged women (Cotofana et al., 2010). 
The MRI images were then analysed by manual planimetry using a hand-writable liquid 
 
 
crystal display (Cintiq 17SX; WACOM, Tokyo, Japan) and image analysis software 
(NIH Image ver. 1.62; National Institute of Health, USA) on a personal computer 
(Macintosh Power PC; Apple, Tokyo, Japan). The DICOM image data from MRI were 
converted into 652 × 652 pixels JPEG picture images. The MRI scans were assessed in 
a blind manner, i.e. the identity of the subject was not revealed. The regions of 
thigh-muscle CSA included quadriceps femoris, hamstrings and adductor magnus 
muscles. Thigh-muscle CSA was measured from the mean value of three traces. 
 
Measurement of daily physical activity 
Daily physical activity was measured using a uniaxial accelerometer 
(Life-Corder; Suzuken, Nagoya, Japan). All subjects wore the accelerometer on their 
waist continuously for 14 days, except during sleeping and bathing. The total physical 
energy expenditure (kcal) was calculated from the energy measured by the 
accelerometer combined with a questionnaire based on the compendium of physical 
activity (Ainsworth et al., 1993), which was administered to all subjects.  
 
Measurements of blood components 
Subjects were instructed to abstain from vigorous exercise and fast on the day 
 
 
prior to the measurements. Plasma glucose concentrations and fasting serum 
concentrations of cholesterol and triglycerides were determined using standard 
enzymatic techniques. 
 
Statistical analysis 
Statistical analyses were performed using SPSS Base System 14.0 J for 
Windows (SPSS Japan, Tokyo, Japan). ACTN3 R577X genotype distribution was 
evaluated for conformity with the Hardy-Weinberg equilibrium using the χ2 test with 
one degree of freedom. Subjects were divided into two age groups (middle-aged and 
older) by median age (60 years). Differences in physical characteristics between the XX, 
RR and RX genotypes were tested using analysis of variance (ANOVA), and between 
the XX and RR&RX genotypes using unpaired t-tests. Thigh-muscle CSA was 
compared between the genotype groups using an analysis of covariance (ANCOVA) 
model with age and body weight. Values are expressed as mean ± SE; P < 0.05 is 
considered to be statistically significant.  
 
 
 
 
 
RESULTS 
To clarify the influence of ACTN3 R577X polymorphism and the effect of 
aging on muscle mass, we divided the subjects into the middle-aged (n = 82; mean 50.6 
± 0.9 years) and the older (n = 80; mean 66.8 ± 0.5 years) groups, with the dividing line 
set at the median value (60 years) of age. Table 1 shows the characteristics of the 
middle-aged group and older group. As the results, the older group had low body weight 
and thigh-muscle CSA, less physical activity, and higher blood glucose and triglyceride 
compared with the middle-aged group (P < 0.05).   
 The ACTN3 R577X genotype distributions in the all subjects were 16%, 55% 
and 29%, RR, RX and XX respectively. The genotype frequencies were in 
Hardy-Weinberg equilibrium (χ2 value = 2.24, df = 1, P = 0.14). Also, in the subgroups, 
the genotype frequencies were in Hardy-Weinberg equilibrium (middle-aged group: χ2 
value = 0.47, P = 0.49 and older group: χ2 value = 2.09, P = 0.15). The characteristics of 
all subjects were not significant differences among ACTN3 R577X genotypes. In the 
middle-aged group, no significant differences were found for all characteristics among 
ACTN3 R577X genotypes (Table 2 and Figure 1). However, the older group indicated 
that only thigh-muscle CSA that was adjusted to age and body weight was different 
between the XX genotype and the RR&RX genotype (Figure 1). The other 
 
 
characteristics in the older group did not indicate significant differences (Table 3).  
 
 
 
DISCUSSION 
This study investigated the relation between ACTN3 R577X polymorphism and 
thigh-muscle CSA in different age groups of women. No significant differences were 
found between ACTN3 R577X genotype in the middle-aged group. However, the older 
group showed that the XX genotype was associated with smaller thigh-muscle CSA 
compared to the RR&RX genotype. These findings suggest that the influence of ACTN3 
R577X polymorphism on muscle change with aging. Previous reports have described 
that gene polymorphisms are associated with age-related changes in left-ventricular 
mass (Peter et al., 2007) and carotid artery elasticity (Hanon et al., 2001). The present 
report is the first to describe that the relation between ACTN3 R577X polymorphism 
and skeletal muscle is associated with age.  
 
 Previous reports have described the relation between ACTN3 R577X 
polymorphism and muscle mass in women (Walsh et al., 2008; Zempo et al., 2010). 
 
 
These findings are supported by findings related to Actn3 knockout mice, which 
simulating the human XX genotype (MacArthur et al., 2008). The present study 
investigated that relation in middle-aged group, but no relation was found. In addition, 
Clarkson et al. (2005) reported that no relation exist between ACTN3 R577X 
polymorphism and arm muscle CSA in younger women. These suggest the possibility 
that the relation between ACTN3 R577X polymorphism and muscle mass does not 
emerge in younger and middle-aged women. In contrast, Walsh et al. demonstrated that 
the XX genotype had lower fat-free mass than the RR&RX genotype in women across 
the adult age span (22-90 years old) (Walsh et al., 2008). Their study measured whole 
and leg fat-free mass as muscle mass using dual-energy X-ray absorptiometry. 
Therefore, the differences of the measurement methods of muscle mass and 
measurement area of body might influence the results. Delmonico et al. assessed 
longitudinal mid-thigh muscle CSA changes in ACTN3 R577X polymorphism in 70-79 
years old Caucasian women (Delmonico et al., 2008) but found no differences of 
baseline and change CSA after 5 years. Instead, the differences were apparently 
attributable to ethnic group, body size, living habits, and other factors. More studies 
using common measurements of various subjects are needed. 
 
 
 
 The mechanisms by which ACTN3 R577X polymorphism affects muscle mass 
remain unknown. We assume that ACTN3 R577X polymorphism affects sarcopenia. A 
major characteristic of sarcopenia is selective atrophy of type II muscle fibers (Kamel, 
2003). Although type II fibers express a large amount of ACTN3, the XX genotype has 
been shown to result in loss of ACTN3. Alternatively, type II fibers of the XX genotype 
replace ACTN3 with ACTN2 (North et al., 1996). In fact, ACTN2 is a closely related 
homolog of ACTN3 that is expressed in all muscle fibers. Previous studies showed that 
loss of ACTN3 (or Actn3) affects muscle mass in humans and mice (Walsh et al., 2008; 
Zempo et al., 2010; MacArthur et al., 2008). These findings suggest that ACTN2 is 
insufficient as a replacement of ACTN3 in the XX genotype. Therefore, it is predicted 
that atrophy occurs easily in the type II fiber solely comprising ACTN2. Vincent et al. 
reported that the type II fiber diameter of the XX genotype is comparable with that of 
the RR genotype in younger adults (Vincent et al., 2007). Nevertheless, it is not clear 
that muscle fiber characteristics of the XX genotype in older adults remain unchanged. 
More research is necessary to elucidate the relation between ACTN3 R577X 
polymorphism and muscle. 
 
Results of previous studies have shown that sex-specific genotype differences 
 
 
for ACTN3 R577X polymorphism are particularly prevalent among women (Clarkson et 
al., 2005; Walsh et al., 2008; Delmonico et al., 2008; Yang et al., 2003). Results of 
those studies present the possibility that the sex-hormone influences the phenotypes. In 
general, sex hormones decrease after menopause in women. Another report described 
that, in women, an accelerated loss of muscle mass and strength occurs around the time 
of menopause (Maltais et al., 2009). Therefore, the influence of ACTN3 R577X 
polymorphism on muscle might arise depending on the postmenopause. 
 
 We also measured physical activity and health status (disease and medications). 
It is important to ask patients about resistance training habits because resistance training 
increases muscle mass (Hunter et al., 2000). We determined physical activity based on 
both actual measurements using an accelerometer and using a questionnaire. Results 
showed that subjects performed standard physical activity (Zhang et al., 2003) and did 
not exercise regularly using resistance training. Although antihypertension medication 
and dyslipidemia-improving drugs can alter muscle mass (Harper and Jacobson, 2010; 
Di Bari et al., 2004), the subjects of our study used no such drugs. The subjects of this 
study were regarded as healthy, implying that their results are applicable to the general 
population. 
 
 
 
This investigation was limited because the study was conducted using a 
cross-sectional design. The best method of determining the influence of ACTN3 R577X 
polymorphism on muscle mass with aging may be longitudinal examination. The 
relations described herein will be clarified further by performing such a longitudinal 
examination. Moreover, we did not conduct survey of menopause status and nutritional 
intake which influences muscle mass. Future studies should include these factors which 
vary with increase in age. 
 
In conclusion, this present study showed an association between ACTN3 
R577X polymorphism and smaller thigh-muscle CSA in a group of elderly women, but 
not in a group of middle-aged women. The results suggest that the influence of ACTN3 
R577X polymorphism on muscle change with ageing. For individuals with XX 
genotype, precautionary measure to prevent or minimize muscle loss should be advised 
before they become older adults. 
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Table 1. Characteristics of the subjects by age group. 
  All subjects   Middle-aged   Older   P value 
(middle-aged vs. 
older)   (n =162)   (n = 82)   (n = 80)   
Age (years old) 58.6 ± 0.8  50.6 ± 0.9  66.8 ± 0.5  0.001* 
Height (cm) 153.1 ± 0.5  155.8 ± 0.7  150.3 ± 0.7  0.001* 
Body weight (kg) 54.0 ± 0.6  55.9 ± 0.9  52.0 ± 0.7  0.001* 
BMI (kg/m2) 23.0 ± 0.2  23.0 ± 0.3  23.0 ± 0.3  0.967 
Thigh-muscle CSA (cm2) 79.0 ± 1.2  86.5 ± 1.7  71.3 ± 1.2  0.001* 
Physical activity (kcal/day) 196.8 ± 8.1  227.0 ± 12.5  165.9 ± 9.0  0.001* 
Blood components           
   Glucose (mg/dl) 98.0 ± 1.1  96.7 ± 1.0  99.3 ± 2.0  0.252 
   Total cho (mg/dl) 214.4 ± 2.8  208.4 ± 4.1  220.5 ± 3.8  0.030* 
   HDL-cho (mg/dl) 60.6 ± 1.0  60.3 ± 1.5  61.0 ± 1.3  0.740 
   LDL-cho (mg/dl) 130.0 ± 2.4  126.6 ± 3.6  133.5 ± 3.2  0.156 
   Triglycerides (mg/dl) 97.5 ± 4.5   89.6 ± 6.5   105.5 ± 6.1   0.079 
Values are means ± SE. BMI, Body mass index; CSA, cross-sectional area. cho, cholesterol; HDL, high density lipopretein; LDL, low 
density lipoprotein. *P < 0.05. 
 
Table 2. Characteristics of the subject by ACTN3 R577X genotype in middle-aged group. 
   RR (a)    RX (b)    RR&RX (c)    XX (d)   P Value P Value 
  (n = 13)   (n = 43)   (n = 56)   (n = 26)   (a vs. b vs. d) (c vs. d) 
Age (years old) 51.2 ± 2.2  51.0 ± 1.4  51.0 ± 1.2  49.7 ± 1.6  0.814 0.522 
Height (cm) 155.8 ± 1.5  156.1 ± 0.9  156.0 ± 0.8  155.4 ± 1.2  0.895 0.662 
Body weight (kg) 55.2 ± 3.3  56.5 ± 1.1  56.2 ± 1.1  55.1 ± 1.5  0.745 0.561 
BMI (kg/m2) 22.7 ± 1.2  23.2 ± 0.5  23.1 ± 0.5  22.8 ± 0.5  0.777 0.634 
Physical activity (kcal/day) 197.7 ± 25.8  235.5 ± 19.4  226.7 ± 16.1  225.6 ± 18.5  0.573 0.966 
Blood components               
   Glucose (mg/dl) 93.8 ± 2.4  98.0 ± 1.4  97.0 ± 1.2  96.0 ± 1.7  0.293 0.618 
   Total cho (mg/dl) 192.5 ± 9.8  212.8 ± 5.7  208.1 ± 5.0  209.0 ± 7.1  0.221 0.916 
   HDL-cho (mg/dl) 64.5 ± 3.7  58.2 ± 1.9  59.6 ± 1.7  61.7 ± 3.0  0.282 0.518 
   LDL-cho (mg/dl) 108.5 ± 8.4  130.0 ± 5.2  125.0 ± 4.6  130.0 ± 5.9  0.093 0.528 
   Triglycerides (mg/dl) 64.8 ± 8.4   103.8 ± 11.0   94.7 ± 8.9   78.7 ± 7.4   0.058 0.256 
Values are means ± SE. BMI, Body mass index; CSA, cross-sectional area. cho, cholesterol; HDL, high density lipopretein; LDL, low 
density lipoprotein. 
Table 3. Characteristics of the subject by ACTN3 R577X genotype in older group. 
   RR (a)    RX (b)    RR&RX (c)    XX (d)   P Value P Value 
  (n = 13)   (n = 46)   (n = 59)   (n = 21)   (a vs. b vs. d) (c vs. d) 
Age (years old) 67.0 ± 1.2  66.6 ± 0.7  66.7 ± 0.6  67.0 ± 1.0  0.933 0.813 
Height (cm) 149.9 ± 1.8  150.6 ± 0.9  150.4 ± 0.8  149.9 ± 1.2  0.881 0.729 
Body weight (kg) 51.5 ± 1.8  51.8 ± 1.0  51.7 ± 0.8  52.9 ± 1.4  0.783 0.489 
BMI (kg/m2) 22.9 ± 0.6  22.8 ± 0.4  22.9 ± 0.3  23.5 ± 0.6  0.564 0.285 
Physical activity (kcal/day) 178.7 ± 20.5  167.0 ± 11.8  169.6 ± 10.2  155.5 ± 19.1  0.714 0.494 
Blood components               
   Glucose (mg/dl) 96.1 ± 2.0  96.1 ± 1.1  96.1 ± 1.0  108.2 ± 7.0  0.259 0.103 
   Total cho (mg/dl) 224.9 ± 7.5  216.7 ± 5.4  218.5 ± 4.5  226.0 ± 6.8  0.508 0.382 
   HDL-cho (mg/dl) 58.1 ± 4.3  62.8 ± 1.7  61.8 ± 1.6  58.6 ± 2.3  0.260 0.298 
   LDL-cho (mg/dl) 132.9 ± 6.8  129.8 ± 4.4  130.5 ± 3.7  142.0 ± 6.2  0.275 0.115 
   Triglycerides (mg/dl) 125.2 ± 23.2   102.0 ± 7.5   107.1 ± 7.8   101.0 ± 8.4   0.369 0.665 
Values are means ± SE. BMI, Body mass index; CSA, cross-sectional area. cho, cholesterol; HDL, high density lipopretein; LDL, low 
density lipoprotein. 
